Clinical Trials
Clinical Trials

Our Current Trials

A Phase 1/2 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

This Phase 1/2 trial is currently recruiting adult patients.

Learn more